Production (Stage)
Coya Therapeutics, Inc.
COYA
$5.62
-$0.01-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.31M | -2.92M | -4.02M | -2.89M | -5.05M |
| Total Depreciation and Amortization | 6.80K | 6.80K | 6.80K | 6.80K | 6.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.08M | 790.50K | 775.00K | 662.30K | 460.70K |
| Change in Net Operating Assets | 3.39M | -291.40K | -2.22M | -2.34M | 6.73M |
| Cash from Operations | -2.83M | -2.41M | -5.46M | -4.56M | 2.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -25.00K |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -25.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.10K | 9.69M | -- | 5.15M | 1.37M |
| Repurchase of Common Stock | -- | -- | -56.30K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -131.90K |
| Cash from Financing | 19.10K | 9.69M | -56.30K | 5.15M | 1.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.81M | 7.28M | -5.52M | 585.70K | 3.36M |